|
|
Post by mango on Jan 12, 2019 21:17:22 GMT -5
Sports posted this in the MNKD twitter page, thought I'd put it in here too  Inhaled insulin can be boon to diabetes sufferers, says JDRFJan. 12, 2019 JDRF, formerly known as the Juvenile Diabetes Research Foundation, is advising adults living with diabetes of the benefits of inhaling insulin close to, or even during, meal times. The medication, with the brand name Afrezza, is a fast-acting insulin that complements other ways of introducing the hormone into the body. Afrezza was first approved by the Food and Drug Administration in 2014. It is prescribed only to individuals over 18. JDRF is supportive of the medication, which can reduce considerably the number of injections insulin-dependent adults need daily. Sanjoy Dutta, an assistant vice president at JDRF who specializes in research and international partnerships, said Afrezza is a product "very close to our hearts" because those with diabetes always need more options. While there have been advances and improvements in medications dealing with diabetes, injections have been used for 95 years, Dutta noted. "So Afrezza has advantages and we support, believe in [it]," Dutta told Patient Daily. "It is a very fast-acting insulin that can manage the meal-time high." The inhaled insulin can be taken just prior to a meal or, if someone forgets, during and even after one. An injection often lasts long after a meal is consumed, beyond the point when the insulin is needed. While most insulin-dependent individuals either have no issue with needles or have overcome their fears, inhaled insulin has the advantage of reducing the number of injections, Dutta said. Instead of injecting four or five times a day, it is possible only one shot would be needed, he added. Many insulin-dependent people use an insulin pump, which is designed to regulate and regularly introduce insulin into the body. But some people do not like to be tethered to a device on their body, and there are other challenges in maintaining a pump. In addition, the Associated Press reported in November that insulin pumps and their components were the subject of more reports to the FDA about malfunction, injury and death than other medical devices. And even for those using the pump, inhaled insulin can act as a complement to make the glucose control better, Dutta said. patientdaily.com/stories/511718551-inhaled-insulin-can-be-boon-to-diabetes-sufferers-says-jdrf |
|
|
|
Post by brotherm1 on Jan 12, 2019 22:39:17 GMT -5
That’s beautiful. Thank you Sport
|
|
|
|
Post by centralcoastinvestor on Jan 12, 2019 22:55:55 GMT -5
Well that was a nice plug for Afrezza from JDRF. Thanks Sports for finding it. And Mango for posting. |
|
|
|
Post by kc on Jan 14, 2019 17:05:48 GMT -5
Sports posted this in the MNKD twitter page, thought I'd put it in here too Inhaled insulin can be boon to diabetes sufferers, says JDRFJan. 12, 2019 JDRF, formerly known as the Juvenile Diabetes Research Foundation, is advising adults living with diabetes of the benefits of inhaling insulin close to, or even during, meal times. The medication, with the brand name Afrezza, is a fast-acting insulin that complements other ways of introducing the hormone into the body. Afrezza was first approved by the Food and Drug Administration in 2014. It is prescribed only to individuals over 18. JDRF is supportive of the medication, which can reduce considerably the number of injections insulin-dependent adults need daily. Sanjoy Dutta, an assistant vice president at JDRF who specializes in research and international partnerships, said Afrezza is a product "very close to our hearts" because those with diabetes always need more options. While there have been advances and improvements in medications dealing with diabetes, injections have been used for 95 years, Dutta noted. "So Afrezza has advantages and we support, believe in [it]," Dutta told Patient Daily. "It is a very fast-acting insulin that can manage the meal-time high." The inhaled insulin can be taken just prior to a meal or, if someone forgets, during and even after one. An injection often lasts long after a meal is consumed, beyond the point when the insulin is needed. While most insulin-dependent individuals either have no issue with needles or have overcome their fears, inhaled insulin has the advantage of reducing the number of injections, Dutta said. Instead of injecting four or five times a day, it is possible only one shot would be needed, he added. Many insulin-dependent people use an insulin pump, which is designed to regulate and regularly introduce insulin into the body. But some people do not like to be tethered to a device on their body, and there are other challenges in maintaining a pump. In addition, the Associated Press reported in November that insulin pumps and their components were the subject of more reports to the FDA about malfunction, injury and death than other medical devices. And even for those using the pump, inhaled insulin can act as a complement to make the glucose control better, Dutta said. patientdaily.com/stories/511718551-inhaled-insulin-can-be-boon-to-diabetes-sufferers-says-jdrfThis is really a big deal when you read the article. Please repost it to any blog or facebook page you can.
patientdaily.com/stories/511718551-inhaled-insulin-can-be-boon-to-diabetes-sufferers-says-jdrf
|
|
|
|
Post by mannmade on Jan 14, 2019 17:13:17 GMT -5
I agree KC. This is where a good PR firm would be of tremendous help to mnkd in placing articles that state this where pwd will read it.
|
|
|
|
Post by sportsrancho on Jan 14, 2019 17:20:16 GMT -5
Where is the PR person? And where is the new Afrezza marking?
|
|
|
|
Post by goyocafe on Jan 14, 2019 17:24:26 GMT -5
Where is the PR person? And where is the new Afrezza marking? What do you expect from a box of crackerjacks?! I think the acid test will be when they actually update the pipeline page on their website. Until that happens, all they’ve done is start spending money on ads again. |
|
|
|
Post by mannmade on Jan 14, 2019 17:26:07 GMT -5
in most companies Corporate Communications and Press Relations are distinct and separate disciplines requiring different skill sets. This is not to say that a valid and robust communication strategy should not be part of a complete marketing strategy and plan.
|
|
|
|
Post by mnholdem on Jan 14, 2019 18:06:33 GMT -5
I agree KC. This is where a good PR firm would be of tremendous help to mnkd in placing articles that state this where pwd will read it. I have been unable to find information on Patient Daily (subscription rates) because the keywords are so common. I once published an article with the disclaimer that it could be reprinted with permission from the author. I received seven requests for reprint from other publications. My point, I suppose, is that I'm wondering how many healthcare professionals or people with diabetes have even read the article? |
|
|
|
Post by mango on Jan 14, 2019 18:41:20 GMT -5
Patient daily shows the article has been shared 96 times, and is showing up under Trending and More Stories when I click on other articles within same category. Would be nice if JDRF had this on their website and social media pages.
|
|
|
|
Post by goyocafe on Jan 14, 2019 18:44:02 GMT -5
Patient daily shows the article has been shared 96 times, and is showing up under Trending and More Stories when I click on other articles within same category. Would be nice if JDRF had this on their website and social media pages. Hmmm, did I hear someone mention a MNKD marketing/corporate communications push is in order. I hope they are not on autopilot. |
|
|
|
Post by mnholdem on Jan 14, 2019 19:05:06 GMT -5
Patient daily shows the article has been shared 96 times, and is showing up under Trending and More Stories when I click on other articles within same category. Would be nice if JDRF had this on their website and social media pages. MannKind's website has a News & Events page, for which readers are given three choices: Press Releases
Events
WebcastsI think it would be a great idea to add another category to the New & Events page: In the NewsLinks to related news stories? Many biotech and pharma companies have these on their websites. |
|
|
|
Post by goyocafe on Jan 14, 2019 19:09:50 GMT -5
Patient daily shows the article has been shared 96 times, and is showing up under Trending and More Stories when I click on other articles within same category. Would be nice if JDRF had this on their website and social media pages. MannKind's website has a News & Events page, for which readers are given three choices: Press Releases
Events
WebcastsI think it would be a great idea to add another category to the New & Events page: In the NewsLinks to related news stories? Many biotech and pharma companies have these on their websites. HELLO! McMNKD! youtu.be/JhJGOYJo9mM |
|
|
|
Post by itellthefuture777 on Feb 8, 2019 0:12:10 GMT -5
Sports posted this in the MNKD twitter page, thought I'd put it in here too Inhaled insulin can be boon to diabetes sufferers, says JDRFJan. 12, 2019 JDRF, formerly known as the Juvenile Diabetes Research Foundation, is advising adults living with diabetes of the benefits of inhaling insulin close to, or even during, meal times. The medication, with the brand name Afrezza, is a fast-acting insulin that complements other ways of introducing the hormone into the body. Afrezza was first approved by the Food and Drug Administration in 2014. It is prescribed only to individuals over 18. JDRF is supportive of the medication, which can reduce considerably the number of injections insulin-dependent adults need daily. Sanjoy Dutta, an assistant vice president at JDRF who specializes in research and international partnerships, said Afrezza is a product "very close to our hearts" because those with diabetes always need more options. While there have been advances and improvements in medications dealing with diabetes, injections have been used for 95 years, Dutta noted. "So Afrezza has advantages and we support, believe in [it]," Dutta told Patient Daily. "It is a very fast-acting insulin that can manage the meal-time high." The inhaled insulin can be taken just prior to a meal or, if someone forgets, during and even after one. An injection often lasts long after a meal is consumed, beyond the point when the insulin is needed. While most insulin-dependent individuals either have no issue with needles or have overcome their fears, inhaled insulin has the advantage of reducing the number of injections, Dutta said. Instead of injecting four or five times a day, it is possible only one shot would be needed, he added. Many insulin-dependent people use an insulin pump, which is designed to regulate and regularly introduce insulin into the body. But some people do not like to be tethered to a device on their body, and there are other challenges in maintaining a pump. In addition, the Associated Press reported in November that insulin pumps and their components were the subject of more reports to the FDA about malfunction, injury and death than other medical devices. And even for those using the pump, inhaled insulin can act as a complement to make the glucose control better, Dutta said. patientdaily.com/stories/511718551-inhaled-insulin-can-be-boon-to-diabetes-sufferers-says-jdrf Nice! |
|
|
|
Post by mannmade on Feb 8, 2019 11:21:19 GMT -5
Still do not understand why mnkd did not do more with this. It is an endorsement from one of two leading diabetes groups in US. Should also be using with doctors and insurance companies if not already.
|
|
